Journals / Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları / 2021 / Cilt: 5 - Sayı: 1

Have COVID-19 Pandemic Restrictions Impacted the Functioning of the Hematology Clinic?

COVID-19 Pandemi Kısıtlamaları Hematoloji Kliniğinin İşlevselliğini Etkiledi Mi?

Pages
5–10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study highlights the cruciality and functionality of hematology patient management during the period of lockdown restrictions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of our study is to assess the clinical functioning of hematology during the COVID-19 pandemic when lockdown restrictions are enforced.
📊
Key Findings & Data:Patients and Methods: Patients who were admitted to Necmettin Erbakan University Meram Medical Faculty and Istanbul Medipol University Medical Faculty Adult Hematology clinics between March 13, 2020, and May 15, 2020, when lockdown restrictions were enforced in the first phase of the pandemic were evaluated retrospectively by comparing them with those who were admitted to same clinics between March 13, 2019, and May 15, 2019.
💡
Conclusion & Impact:Conclusion: Our study highlights the cruciality and functionality of hematology patient management during the period of lockdown restrictions.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of our study is to assess the clinical functioning of hematology during the COVID-19 pandemic when lockdown restrictions are enforced. Patients and Methods: Patients who were admitted to Necmettin Erbakan University Meram Medical Faculty and Istanbul Medipol University Medical Faculty Adult Hematology clinics between March 13, 2020, and May 15, 2020, when lockdown restrictions were enforced in the first phase of the pandemic were evaluated retrospectively by comparing them with those who were admitted to same clinics between March 13, 2019, and May 15, 2019. Results: The number of inpatients during both periods was 266. It was determined that during the period of the pandemic, the number of patients hospitalized for diagnostic purposes was significantly higher compared to 2019 (OR: 2.1, 95% CI: 1.35-3.26, p< 0.001), whereas the rate of hospitalization due to any infection was significantly lower (OR: 0.44, 95% CI: 0.27-0.71, p<0.001). Of the patients who were hospitalized for diagnostic purposes in 2020, both the rate of male patients was higher (OR: 0.4, 95% CI: 0.18-0.92, p= 0.031) and the duration of hospitalization was longer (7 vs. 14 days; p= 0.007) found. While the rate of patients hospitalized due to the need for replacement was also higher during the period of pandemic (OR: 4.7, 95% CI; 1.7-12.6, p< 0.001), when all patients were assessed, the frequency of blood product use was not different between two years. Conclusion: Our study highlights the cruciality and functionality of hematology patient management during the period of lockdown restrictions.

Özet

Amaç: Çalışmamızın amacı, kısıtlamaların uygulandığı COVID-19 pandemi sürecinde hematoloji klinik işleyişinin değerlendirilmesidir. Hastalar ve Yöntem: Pandeminin ilk döneminde sokağa çıkma kısıtlamalarının uygulandığı 13.03.2020-15.05.2020 ile bu tarih aralığına karşılık gelen 2019 döneminde Necmettin Erbakan Üniversitesi Meram Tıp Fakültesi ve İstanbul Medipol Üniversitesi Tıp Fakültesi Erişkin Hematoloji kliniklerine yatışı yapılan hastalar retrospektif olarak değerlendirildi. Bulgular: Her iki dönemde de yatan hasta sayısı 266 idi. 65 yaş üstü hasta oranı anlamlı olmamakla birlikte 2020’de daha düşük saptandı (%33.1’e kaşın %40.6, p= 0.72). Pandemi döneminde 2019’a göre tanısal amaçlı yatışı yapılan hasta sayısı anlamlı olarak yüksek (OR: 2,1, %95 GA: 1.35-3.26, p< 0.001); herhangi bir enfeksiyon nedeniyle yatış oranı ise düşük (OR: 0,44, %95 GA: 0.27-0.71, p< 0.001) bulundu. Tanısal amaçlı yatış yapılan hastalarda 2020 yılında hem erkek hasta oranı yüksek (OR: 0.4, %95 GA: 0.18-0.92, p= 0.031) hem de yatış süresi daha uzun (medyan 7’ye 14 gün, p= 0.007) bulundu. Kemoterapi, destek ve mobilizasyon amaçlı yatışlar arasında fark saptanmadı. Replasman ihtiyacı nedeniyle yatışı yapılan hasta oranı yine pandemic döneminde yüksek iken (OR: 4.7, %95 GA: 1.7-12.6, p< 0.001), tüm hastalar değerlendirildiğinde kan ürünü kullanımı sıklığı iki yıl arasında farklı değildi. Sonuç: Çalışmamız, kısıtlamalar sürecinde hematoloji hasta yönetiminin önemini ve işlevselliğinin değişmediğini vurgulamaktadır.

🔖

Cite This Article

TEKİNALP, A., GEMİCİ, A., DİKİCİ, H. Z., KARS, T. U., USTA, F. S., DEMİRCİOĞLU, S., ÇENELİ, Ö. (2021). Have COVID-19 Pandemic Restrictions Impacted the Functioning of the Hematology Clinic?. Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları, Cilt: 5 - Sayı: 1, 5–10. https://ajindex.com/articles/413984

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bhandari S, Shaktawat AS, Patel B, Dube A, Kakkar S, Tak A, et al. The sequel to COVID-19: the antithesis to life. Journal of Ideas in Health 2020;3(Special1):205-12
  2. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr 2020;87(4):281-6
  3. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020;109:102433
  4. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients with Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol 2020;6(7):1108-10
  5. Halfdanarson TR, Hogan WJ, Madsen BE. Emergencies in Hematology and Oncology. Mayo Clin Proc 2017;92(4):609-41
  6. Gavillet M, Rufer N, Grandoni F, Klappert JC, Zermatten MG, Cairoli A, et al. Hematology in the time of COVID-19. Rev Med Suisse 2020;16(691-692):823-6
  7. World Health Organization (WHO). WHO Coronairus Disease (COVID-19) Dashboard. Available from:
  8. Marron JM, Joffe S, Jagsi R, Spence RA, Hlubocky FJ. Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID19 pandemic. J Clin Oncol 2020;38(19):2201-5
  9. Shah MA, Emlen MF, Shore T, Mayer S, Leonard JP, Rossi A, et al. Hematology and Oncology Clinical Care During the Coronavirus Disease 2019 Pandemic. CA Cancer J Clin 2020;70(5):349-54
  10. Soytaş M, Boz MY, Güzelburç V, Çalık G, Horuz R, Akbulut Z, et al. Comparison of before and after COVID-19 urology practices of a pandemic hospital Turk J Urol 2020;46(6):474-80
  11. Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 2009;113(18):4179-87
  12. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107(1):265-76
  13. Landgren O, Weiss BM. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia 2009;23(10):1691-7
  14. Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Eur J Haematol 2015;96(5):447-60
  15. Ojetti V, Covino M, Brigida M, Petruziello C, Saviano A, Migneco A, et al. Non-COVID Diseases during the Pandemic: Where Have All Other Emergencies Gone? Medicina (Kaunas) 2020;56(10):512-22. 16.